Related Experiment Video
Updated: Jan 17, 2026

Quantification of Colonic Stem Cell Mutations
Published on: September 25, 2015
Interesting Case of Celphos Poisoning with G6PD Deficiency: Is There a Correlation?
Nitin Wadaskar1, Prafulla Doifode2, Rahul Arora3
1Senior Consultant, Department of General Medicine, Max Super Speciality Hospital, Nagpur, Maharashtra, India, Corresponding Author.
Celphos poisoning, common in India, lacks a specific antidote and often leads to severe outcomes. This case highlights successful treatment of hemolysis in a patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency after Celphos ingestion.
Area of Science:
- Toxicology
- Hematology
- Internal Medicine
Background:
- Celphos (aluminum phosphide) poisoning is a significant public health concern in agricultural regions like India, characterized by high mortality and lack of a specific antidote.
- Clinical presentation is variable, and while multisystem involvement is common, hematological complications are considered infrequent.
- Management relies on supportive care and intensive monitoring due to the potential for multiorgan failure.
Purpose of the Study:
- To report a successfully treated case of Celphos poisoning.
- To highlight the association between Celphos poisoning, hemolysis, and glucose-6-phosphate dehydrogenase (G6PD) deficiency.
- To emphasize the importance of considering G6PD deficiency in patients presenting with hemolysis after Celphos ingestion.
Main Methods:
- Case report of a young male with accidental Celphos consumption and delayed presentation.
- Clinical evaluation for signs of hemolysis.
- Diagnostic workup including assessment for glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Main Results:
- The patient presented with clinical features suggestive of hemolysis.
- Subsequent evaluation revealed the presence of glucose-6-phosphate dehydrogenase (G6PD) deficiency.
- The patient received supportive care and was successfully treated despite delayed presentation.
Conclusions:
- Celphos poisoning can precipitate hemolysis, particularly in individuals with underlying G6PD deficiency.
- Early recognition and management of hematological complications, such as hemolysis in G6PD-deficient individuals, are crucial for favorable outcomes.
- This case underscores the need for heightened awareness of G6PD deficiency in the context of Celphos poisoning and hemolysis.
Related Concept Videos
Inborn Errors of Metabolism
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Prevention of Further Absorption of Poison
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

